Serum levels of glial cell line-derived neurotrophic factor as a biomarker for mood disorders and lithium response.

MLA

Idemoto, Keita, et al. “Serum Levels of Glial Cell Line-Derived Neurotrophic Factor as a Biomarker for Mood Disorders and Lithium Response.” Psychiatry Research, vol. 301, July 2021, p. 113967. EBSCOhost, https://doi.org/10.1016/j.psychres.2021.113967.

APA

Idemoto, K., Niitsu, T., Hata, T., Ishima, T., Yoshida, S., Hattori, K., Horai, T., Otsuka, I., Yamamori, H., Toda, S., Kameno, Y., Ota, K., Oda, Y., Kimura, A., Hashimoto, T., Mori, N., Kikuchi, M., Minabe, Y., Hashimoto, R., … Iyo, M. (2021). Serum levels of glial cell line-derived neurotrophic factor as a biomarker for mood disorders and lithium response. Psychiatry Research, 301, 113967. https://doi.org/10.1016/j.psychres.2021.113967

Chicago

Idemoto, Keita, Tomihisa Niitsu, Tatsuki Hata, Tamaki Ishima, Sumiko Yoshida, Kotaro Hattori, Tadasu Horai, et al. 2021. “Serum Levels of Glial Cell Line-Derived Neurotrophic Factor as a Biomarker for Mood Disorders and Lithium Response.” Psychiatry Research 301 (July): 113967. doi:10.1016/j.psychres.2021.113967.